CBD gummy recall impacts thousands worldwide

CBD products are increasingly popular in the U.S., with dozens of brands offering everything from lotions to pet supplements. Consumers are being warned about a CBD gummy recall potentially affecting thousands of customers across multiple countries.
RELATED: ‘Especially concerning’: FDA issues warning over CBD product
The Class II recall centers on four varieties of gummies from Colorado-based Extract Labs. The company initiated the voluntary recall after discovering that the products may have been cross-contaminated with peanut protein.
The recalled products include:
- Sugar-free Mixed Berry Gummies
- Elderberry 20mg Gummies
- Blue Razz 20mg Gummies
- Mai Tai 20mg Gummies
Specific batch numbers are listed on the FDA website. The gummies were sold throughout the United States as well as in Australia, Germany, the United Kingdom, Malaysia, and New Zealand. The recall involves more than 61,000 gummies.
RELATED: Weed shops take New York to court
A Class II recall is issued for “a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.” Approximately three percent of American adults have a peanut allergy.
Representatives from Extract Labs did not immediately respond to a request for comment.
Colorado CBD gummy recall is not the only recall affecting market
Recalls in the cannabis space are not uncommon. Most are state-specific and center around products that contain banned pesticides or microbials. Recalls of vapes with cutting agents like MCT oil also happen regularly, as was the case multiple times this year alone in Michigan.
However, allergen-related recalls do occur.
RELATED: Ultra-rare compounds found in weed – here’s why it matters
Earlier this year, regulators in Oregon issued a notice after a brand of cannabis edibles failed to report a key allergen in its ingredient list. In that case, the products were pulled from shelves to be relabeled.
While no company wants to issue a recall, such incidents serve as a reminder of the importance of strict manufacturing oversight. Consumers should stay informed about the news, in case their favorite gummies are affected.